Skip to main content
Impel Pharmaceuticals Inc (IMPLQ)
Apr 5, 2024 - IMPLQ was delisted (reason: shares cancelled)
0.0150
+0.0050 (50.00%)
Inactive · Last trade price on Apr 5, 2024

Impel Pharmaceuticals Revenue

Impel Pharmaceuticals had revenue of $5.02M in the quarter ending September 30, 2023, with 62.98% growth. This brings the company's revenue in the last twelve months to $20.99M, up 155.29% year-over-year. In the year 2022, Impel Pharmaceuticals had annual revenue of $12.65M with 1,794.01% growth.

Revenue (ttm)
$20.99M
Revenue Growth
+155.29%
P/S Ratio
0.02
Revenue / Employee
$131,169
Employees
160
Market Cap
356.24K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202212.65M11.98M1,794.01%
Dec 31, 2021668.00K--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

IMPLQ News

More News